Huons Co., Ltd. (KOSDAQ:243070)

Market Cap	320.43B
Revenue (ttm)	588.31B
Net Income (ttm)	31.88B
Shares Out	11.69M
EPS (ttm)	2,627.14
PE Ratio	10.43
Forward PE	n/a
Dividend	630.00 (2.30%)
Ex-Dividend Date	Jun 27, 2025

Volume	18,959
Average Volume	25,091
Open	27,900
Previous Close	27,900
Day's Range	27,300 - 27,900
52-Week Range	21,800 - 33,300
Beta	0.27
RSI	44.25
Earnings Date	Aug 14, 2025

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory sy...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 912
• Stock Exchange: KOSDAQ
• Ticker Symbol: 243070

Financial Performance

In 2024, Huons's revenue was 590.23 billion, an increase of 6.92% compared to the previous year's 552.01 billion. Earnings were 29.45 billion, a decrease of -41.64%.